Organigram Global (OGI) Price to Sales (2019 - 2025)

Organigram Global's (OGI) quarterly Price to Sales came in at 2.58 in Q4 2025, down 72.06% quarter-over-quarter from 9.23 in Q2 2021.

Analysis

Organigram Global (OGI) Price to Sales (2019 - 2025) Analysis & Trends

Organigram Global (OGI) has reported Price to Sales for 4 consecutive years, with 2.58 the latest figure, recorded in Q4 2025.

On a quarterly basis, Price to Sales changed N/A year-over-year to 2.58 in Q4 2025; TTM through Dec 2025 was 1.16, a N/A change from a year earlier, with the FY2025 full-year figure at 1.13, changed N/A from the prior year.
Price to Sales was 2.58 for Q4 2025 at Organigram Global, down from 9.23 in the prior quarter.
Over five years, Price to Sales peaked at 13.93 in Q1 2021 and troughed at 2.58 in Q4 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Curaleaf Holdings	2.66 Bn	2.56 Bn	169.91 Mn
2	Trulieve Cannabis	2.27 Bn	1.94 Bn	162.29 Mn
3	Green Thumb Industries	1.71 Bn	1.42 Bn	137.87 Mn
4	Cronos	1.18 Bn	379.85 Mn	28.45 Mn
5	Glass House Brands	666.14 Mn	647.59 Mn	15.77 Mn
6	Vireo Growth	545.10 Mn	402.80 Mn	95.30 Mn
7	Tilray Brands	470.81 Mn	236.18 Mn	90.52 Mn
8	Verano Holdings	434.44 Mn	349.24 Mn	99.70 Mn
9	Canopy Growth	406.26 Mn	159.25 Mn	16.08 Mn
10	Organigram Global	141.08 Mn	141.08 Mn	39.15 Mn

Historic Data

Download Data